OHSU Knight Cancer Institute: Brain Neoplasms trials

The registry lists 10 Brain Neoplasms studies with OHSU Knight Cancer Institute as lead sponsor. 2 are open to participants now and 4 have results posted.

Early Phase 1 1Phase 1 2Phase 2 5No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Exercise Intervention for Improving Mental and Physical Health in Patients With Primary Brain Tumors and Their Caregivers, ET-NEURO TrialRecruitingNCT07278440Not applicable
• Gadolinium and Ferumoxytol MRI in Diagnosing Patients With Abnormalities in the Central Nervous SystemRecruitingNCT03270059Phase 2
• Pembrolizumab and Magnetic Resonance Imaging With Ferumoxytol in Treating Patients With Non-small Cell Lung Cancer and Brain MetastasesTerminatedNCT03325166Phase 2Results posted
• DSC-MRI With Ferumoxytol and DCE-MRI With Gadolinium in Imaging Vascular Properties in Younger Patients With Brain TumorsCompletedNCT00978562Early Phase 1Results posted
• Imaging of Intravenous (IV) Combidex to Brain, Intra-cerebral Tumors and in Central Nervous System (CNS) InflammationTerminatedNCT00659334Phase 2Results posted
• Ferumoxytol- and Gadolinium-Labeled MRI in Measuring Tumors Before or After Treatment in Patients With Primary or Metastatic Brain TumorsTerminatedNCT00659126Phase 2Results posted
• Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial TumorsWithdrawnNCT05904704Not applicable
• Ferumoxytol in Magnetic Resonance Imaging of Pediatric Patients With Brain TumorsWithdrawnNCT03234309Phase 2
• Assessing Dynamic Magnetic Resonance (MR) Imaging in Patients With Recurrent High Grade Glioma Receiving ChemotherapyTerminatedNCT00769093Phase 1
• Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsTerminatedNCT00238173Phase 1